TRANSFORMing the Primary Prevention of Coronary Heart Disease with AI/CCTA
In a previous post, the skeptical cardiologist enthusiastically proclaimed CCTA as the ideal tool for assessing stable individuals for the presence, characteristics, and severity of atherosclerotic plaque (aka the atherosclerotic